Загрузка видео...

Не удалось загрузить видео

На главную

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. #Ivermectin #CancerResearch #RepurposedDrugs

Комментарии: 6

Фото профиля Rita O Ryan
Rita O Ryan17 часов назад

simple is always the best

Фото профиля シフト
シフト10 часов назад

👍

Фото профиля Culmont Chalindrey
Culmont Chalindrey9 часов назад

C'est très bien tout ça cher docteur, mais où peut-on en trouver pas cher, comme du temps où elle était en vente libre en pharmacie ?

Фото профиля Rinjani
Rinjani9 часов назад

👍

Фото профиля Christopher
Christopher9 часов назад

I know. I've had this chart for years.

Фото профиля Frank Young
Frank Young10 часов назад

How do you reconcile that your profile says California but your about actually shows your are in the Africa continent?

Похожие видео

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs

RXMEDS.STORE

37,349 просмотров • 2 месяцев назад

🚨 WHY IVERMECTIN DOSING ISN'T ONE SIZE FITS ALL. THIS PHYSICIAN EXPLAINS THE DIFFERENCE. A physician starts with a point that many people overlook: Ivermectin dosing is weight based. So before discussing any amount, she starts with body weight. 📌 Her conversion: Weight in pounds ÷ 2.2 = kilograms Her example: 130 lb ÷ 2.2 ≈ 59 kg But that's only the starting point. She then explains that the amount she discusses changes depending on what Ivermectin is being used for. 💊 PREVENTION 0.2 mg/kg twice a week 💊 PARASITE CLEANSE 0.3 mg/kg She says she then follows the protocol associated with her parasite cleanse. 💊 COVID, FLU OR RSV She describes a range of: 0.4 to 0.6 mg/kg She also explains that she may round the calculated amount upward to an even 5 mg increment. Then comes the most variable category. 💊 CANCER She says the amount can depend on: • Cancer type • Cancer stage • Disease progression • How aggressive the approach is She says she may go as high as: 📈 1 mg/kg or higher Then she gives the principle behind her entire explanation: "It just depends on what you're doing it for." And the lowest amount she says she would use? 📌 0.2 mg/kg But the bigger takeaway from this discussion is simple: Ivermectin dosing depends on what it is being used for, not just body weight. And simply converting pounds to kilograms and applying a number isn't enough to determine an appropriate treatment plan. Indication, formulation, other medications, medical history, and safety all matter. Ivermectin has a long history of human use, but higher doses can increase the risk of adverse effects. The FDA also distinguishes human ivermectin products from veterinary formulations, which are not substitutes for medicines intended for people. And when the indication is experimental, particularly cancer, the dosing question is something clinical research still needs to answer. 📌 Save this post if you're researching Ivermectin dosing and want to understand why there isn't one universal number. 🔄 Repost it so others researching Ivermectin can see the discussion. 💊 Exploring Ivermectin? See why thousands of customers worldwide choose RXMEDS.STORE for pharmaceutical grade Ivermectin. #Ivermectin #IvermectinDosage #IvermectinResearch #RepurposedDrugs #MedicalResearch

RXMEDS.STORE

33,968 просмотров • 25 дней назад

🚨 THIS DOCTOR SAYS IVERMECTIN DOSING CAN CHANGE COMPLETELY DEPENDING ON WHY IT’S BEING USED Most people hear “Ivermectin” and think of one standard dose. That isn't how the speaker in this clip approaches it. They explain that their calculations start with body weight, converting pounds to kilograms, and then applying a milligram-per-kilogram amount based on the situation. For example, they describe: • 0.2 mg/kg for what they call prevention • 0.3 mg/kg for their parasite-cleanse approach • 0.4 to 0.6 mg/kg for patients they describe as having COVID, flu or RSV • For cancer, they say the amount depends on the type, stage and progression, with some aggressive approaches reaching 1 mg/kg or higher They also describe rounding calculated doses to an available strength. Their example: if the calculation comes out to 32 mg, they might prescribe 35 mg. And that's where this conversation gets controversial. The speaker isn't describing one fixed Ivermectin dose. They're describing a range that changes according to the condition and their treatment approach, with cancer being the most aggressive end of the range. But these numbers should be understood as the speaker's claimed clinical approach, not a dosing guide. Ivermectin dosing is indication-specific, and the higher doses described here can carry significant safety concerns. Ivermectin is not an established treatment for COVID-19 or cancer. #Ivermectin #IvermectinResearch #DrugRepurposing #CancerResearch #Pharmacology #MedicalResearch

PharmacyinUSA

16,174 просмотров • 3 дней назад

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,906 просмотров • 1 год назад

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

18,224 просмотров • 1 месяц назад

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 просмотров • 3 месяцев назад